无支架胸主动脉腔内修复术治疗慢性DeBakey IIIb型动脉瘤的结局
本研究纳入2014至2016年间接受无支架胸主动脉腔内修复术(TEVAR)的19例慢性DeBakey IIIb型动脉瘤患者,15例(78.9%)实现胸段假腔血栓化,无死亡,平均随访16.8个月,左锁骨下动脉及肺动脉分叉水平真假腔直径显著改变,无支架TEVAR似乎安全且有利于主动脉重塑。
要点
- 19例慢性DeBakey IIIb型动脉瘤患者接受无支架TEVAR,15例(78.9%)实现胸段假腔血栓化。
- 术后左锁骨下动脉及肺动脉分叉水平假腔直径显著缩小、真腔直径显著增大。
- 无支架TEVAR似乎安全,可用于经过选择的慢性DeBakey IIIb型动脉瘤患者。
核心结论
- 无支架TEVAR似乎是一项安全的手术,能够实现有利的主动脉重塑。
- 因此,该技术可用于经过选择的慢性DeBakey IIIb型动脉瘤患者群体。
研究设计与样本
- 本研究纳入2014年至2016年间接受无支架胸主动脉腔内修复术(TEVAR)治疗慢性DeBakey IIIb型动脉瘤的19例患者。
- 无支架TEVAR定义为使用多种材料闭合交通通道或闭塞假腔本身的血管内手术。
- 胸段假腔血栓化定义为胸主动脉假腔内无血流。
- 主动脉直径在3个水平(左锁骨下动脉、肺动脉分叉及腹腔干)测量。
主要发现
- 19例患者中15例(78.9%)出现胸段假腔血栓化。
- 无死亡,平均随访时间为16.8个月。
- 左锁骨下动脉水平假腔直径由22.6 ± 16.6 mm变为16.1 ± 14.4 mm(p = 0.001),肺动脉分叉水平假腔直径由23.2 ± 14.6 mm变为18.0 ± 13.2 mm(p = 0.002)。
- 左锁骨下动脉水平真腔直径由22.7 ± 8.7 mm变为27.9 ± 6.3 mm(p = 0.001),肺动脉分叉水平真腔直径由19.0 ± 8.3 mm变为24.3 ± 6.7 mm(p = 0.001)。
- 内脏支架移植物数量及术前肺动脉水平真腔直径是胸段假腔血栓化的独立预测因素(风险比3.445,95%置信区间1.494至7.946,p = 0.004;风险比1.106,95%置信区间1.029至1.189,p = 0.006)。
临床怎么用
- 作者认为,无支架TEVAR似乎安全且能实现有利的主动脉重塑,可用于经过选择的慢性DeBakey IIIb型动脉瘤患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We introduce a new endovascular procedure for favorable aortic remodeling in patients with chronic DeBakey IIIb (CDIIIb) aneurysms and present outcomes. METHODS: This study included 19 patients who underwent stentless thoracic endovascular aortic repair (TEVAR) for CDIIIb aneurysms between 2014 and 2016. Stentless TEVAR is defined as an endovascular procedure involving closure of communicating channels or obliteration of the false lumen itself using various materials. Thoracic false lumen thrombosis was defined as there was no flow in the false lumen of the thoracic aorta. Aortic diameter was measured at 3 levels (left subclavian artery, pulmonary artery bifurcation, and celiac axis). RESULTS: Fifteen of 19 (78.9%) patients demonstrated thoracic false lumen thrombosis. There was no mortality, and the mean follow-up duration was 16.8 months. False and true lumen diameters at the left subclavian and pulmonary artery levels significantly changed after the procedure (false lumen: 22.6 ± 16.6 versus 16.1 ± 14.4 mm, 23.2 ± 14.6 versus 18.0 ± 13.2 mm, p = 0.001 and p = 0.002, respectively; true lumen: 22.7 ± 8.7 versus 27.9 ± 6.3 mm, 19.0 ± 8.3 versus 24.3 ± 6.7 mm, p = 0.001 and p = 0.001, respectively). The number of visceral stent grafts and preoperative true lumen diameter at the pulmonary artery were independent predictors for thoracic false lumen thrombosis (hazard ratio, 3.445, 95% confidence interval, 1.494 to 7.946; p = 0.004; and hazard ratio, 1.106; 95% confidence interval, 1.029 to 1.189; p = 0.006, respectively). CONCLUSIONS: Stentless TEVAR seems to be a safe procedure and enables favorable aortic remodeling. Thus, this technique can be useful in a selected group of patients with CDIIIb aneurysms.
引用
- Kim TH, Song SW, Lee KH, et al. Outcomes of Stentless Thoracic Endovascular Aortic Repair for Chronic DeBakey IIIb Aneurysms. Ann Thorac Surg. 2018. PMID: 30086280. doi:10.1016/j.athoracsur.2018.06.057
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。